Join to view full profile
6095 S Fashion BlvdMurray, UT 84107
Phone+1 801-581-2955
Fax+1 801-581-6484
Dr. Rhoads is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Utah HealthResidency, Dermatology, 2011 - 2014
University of Florida College of Medicine JacksonvilleInternship, Internal Medicine, 2008 - 2009
University of Florida College of MedicineClass of 2008
Certifications & Licensure
UT State Medical License 2011 - 2028
HI State Medical License 2021 - 2026
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2014, 2016-2017
Publications & Presentations
PubMed
- Upadacitinib for the Treatment of Recalcitrant Vulvar Lichen Sclerosus.Courtney M Kenyon, Jamie W Rhoads, Margaret M Cocks
Journal of Lower Genital Tract Disease. 2026-07-01 - The role of antibody class and target on subepidermal blistering disease phenotype and management.Raphaella A Lambert, Christiaan H Noot, Zachary Frost, Zachary C Ney, Annika M Hansen
Italian Journal of Dermatology and Venereology. 2026-06-01 - Improving identification of SJS/TEN and its mimics across a large geographic area: Outcomes from a novel telemedicine collaboration.Alise Williams, Julia A Curtis, Jamie Rhoads, Christopher R LaChapelle, Irma D Fleming
Journal of the American Academy of Dermatology. 2026-02-01
Press Mentions
Spesolimab Provides Sustained Improvement of GPP Symptoms and Quality of LifeMay 29th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
